-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R3jA6PUlIAcMQQ6oEGqt4ogrWFjBS+QY2hUOd3J76my2Bgs8Ec7jGCku0PTgEKRO Ip63ZlzSi+WyxeRcIVqP7Q== 0000903423-02-000019.txt : 20020413 0000903423-02-000019.hdr.sgml : 20020413 ACCESSION NUMBER: 0000903423-02-000019 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020118 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: EDAP TMS SA CENTRAL INDEX KEY: 0001041934 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: PARE D'ACTIVITES LA POUDRETTE LAMARTINE STREET 2: 4/6 RE DU DAUPHINE CITY: 69120 VAUIX EN VELIN STATE: I0 MAIL ADDRESS: STREET 1: EDAP TECHNOMED INC STREET 2: TWO BURLINGTON WOODS CITY: BURLINGTON STATE: MA ZIP: 01803 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: UROLOGIX INC CENTRAL INDEX KEY: 0000882873 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411697237 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-48431 FILM NUMBER: 2512065 BUSINESS ADDRESS: STREET 1: 14405 21ST AVE N CITY: MINNEAPOLIS STATE: MN ZIP: 55447 BUSINESS PHONE: 6124751400 MAIL ADDRESS: STREET 1: 14405 21ST AVENUE NORTH CITY: MINNEAPOLIS STATE: MN ZIP: 55447 SC 13G/A 1 edap13ga_1-18.txt OMB APPROVAL OMB Number: 3235-0145 Expires: October 31, 2002 Estimated average burden hours per response...14.9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Amendment No. 1* Urologix, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, Par Value $0.01 Per Share - -------------------------------------------------------------------------------- (Title of Class of Securities) 917273104 - -------------------------------------------------------------------------------- (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.- The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON EDAP TMS S.A. I.R.S. Identification No. not applicable 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION France 5 SOLE VOTING POWER 49,818 shares NUMBER OF SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 375,182 shares EACH REPORTING 7 SOLE DISPOSITIVE POWER PERSON WITH 49,818 shares 8 SHARED DISPOSITIVE POWER 375,182 shares 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 425,000 shares 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 3.2% 12 TYPE OF REPORTING PERSON CO Item 1. (a) Name of Issuer: Urologix, Inc. (b) Address of Issuer's Principal Executive Offices: 14405 21st Avenue North Minneapolis, Minnesota 55447 Item 2. (a) Name of Persons Filing: EDAP TMS S.A. (b) Address of Principal Business Office: Parc D'Activites La Poudrette-Lamartine 4-6 Rue du Dauphine 69120 Vaulx-en-Velin France (c) Citizenship: France (d) Title of Class of Securities: Common Stock, Par Value $0.01 (e) CUSIP Number: 917273104 Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a(n): (a) [ ] Broker or Dealer registered under Section 15 of the Act (15 U.S.C. 78o) (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c) (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c) (d) [ ] Investment Company registered under Section 8 of the Investment Company Act (15 (U.S.C. 80a-8) (e) [ ] Person registered as an investment adviser under Section 203 of the Investment Advisers Act of 1940 (15 U.S.C. 80b-3) or under the laws of any state. (f) [ ] Employee Benefit Plan or Endowment Fund in accordance with Section 240.13d-1(b)(1)(ii)(F) (g) [ ] Parent Holding Company or Control Person in accordance with Section 240.13d-1(b)(ii)(G) (h) [ ] Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813) (i) [ ] Church Plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3) (j) [ ] Group in accordance withss.240.13d-1(b)(1)(ii)(J) Item 4. Ownership (a) Amount Beneficially Owned: 425,000 shares. (b) Percent of Class: 3.2% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 49,818 shares (ii) Shared power to vote or to direct the vote: 375,182 shares (see Item 7) (iii) Sole power to dispose or to direct the disposition of: 49,818 shares (iv) Shared power to direct the disposition of: 375,182 shares (see Item 7) Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the X reporting person has ceased to be [X] the beneficial owner of more than five percent of the class of securities, check the following: Item 6. Ownership of More than Five Percent on Behalf of Another Person Not Applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company In addition to the 49,818 shares held directly by EDAP TMS S.A., the following shares are held by subsidiaries of EDAP TMS S.A.: 161,591 shares held by EDAP Technomed, Inc. 116,504 shares held by Technomed Medical Systems S.A. 97,087 shares held by EDAP Technomed, Inc. Item 8. Identification and Classification of Members of the Group Not Applicable Item 9. Notice of Dissolution of Group Not Applicable Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of such securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry, and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. EDAP TMS S.A. By: /s/ Ian Vawter ------------------------ Ian Vawter Chief Financial Officer January 18, 2002 -----END PRIVACY-ENHANCED MESSAGE-----